MET MetLife, Inc.

QT67

NYSE·Financial Services·Insurance - Life·USA

Latest market price

98.82

-4.75-4.59%

Overview Short InterestFilings

METQT67MetLife, Inc.·NYSE

Overview Short InterestFilings

98.82-4.59%

Loading chart...

Signal & projected range

Analyst consensus risingHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

AFL-2.24%$120.51 MFC-2.98%$44.26 PRU-2.69%$114.99 PUK-1.29%$23.70 UNM-3.70%$90.28 GL-8.09%$154.79 JXN-2.35%$130.19 VOYA-2.65%$95.81

Snapshot

Index	S&P 500	P/E	18.97	EPS (ttm)	5.21	Insider Own	0.37%	Shs Outstand	635.48M	Perf Week	-1.93%

Market Cap	62.80B	Forward P/E	8.86	EPS next Y	11.16	Insider Trans	0.00%	Shs Float	531.46M	Perf Month	1.61%

Enterprise Value	64.84B	PEG	1.91	EPS next Q	-	Inst Own	70.02%	Short Float	2.11%	Perf Quarter	3.81%

Income	3.63B	P/S	0.80	EPS this Y	17.87%	Inst Trans	0.00%	Short Ratio	3.33	Perf Half Y	27.18%

Sales	78.65B	P/B	2.25	EPS next Y	8.94%	ROA	0.48%	Short Interest	11.20M	Perf YTD	25.18%

Book/sh	44.00	P/C	0.48	EPS next 5Y	9.92%	ROE	12.94%	52W High	103.65 -4.66%	Perf Year	25.79%

Cash/sh	203.83	P/FCF	3.79	EPS past 3/5Y	-8.67% -3.31%	ROIC	0.77%	52W Low	67.33 46.77%	Perf 3Y	56.66%

Dividend Est.	2.37 (2.40%)	EV/EBITDA	10.88	Sales past 3/5Y	4.29% 2.57%	Gross Margin	25.55%	Volatility	2.36% 2.06%	Perf 5Y	50.71%

Dividend TTM	2.32 (2.35%)	EV/Sales	0.82	EPS Y/Y TTM	-12.29%	Oper. Margin	6.19%	ATR (14)	2.24	Perf 10Y	137.55%

Dividend Ex-Date	Nov 03, 2026	Quick Ratio	0.65	Sales Y/Y TTM	12.45%	Profit Margin	4.61%	RSI (14)	50.35	Recom	2.21

Dividend Gr. 3/5Y	4.31% 4.31%	Current Ratio	0.65	EPS Q/Q	20.30%	SMA20	0.45%	Beta	0.78	Target Price	108.25

Payout	46.36%	Debt/Eq	0.70	Sales Q/Q	9.90%	SMA50	1.60%	Rel Volume	1.80	Prev Close	103.57

Employees	46,000	LT Debt/Eq	0.64	Earnings	Nov 04	SMA200	16.05%	Avg Volume	3.32M	Price	98.82

IPO Date	Apr 05, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.87% -3.00%	Net Debt/EBITDA	0.34	Volume	5,979,460	Change	-4.59%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Oct-07-26	Reiterated	Barclays	Overweight	$97 → $111
Oct-07-26	Reiterated	Mizuho	Outperform	$95 → $109
Oct-06-26	Reiterated	UBS	Buy	$105 → $110
Sep-22-26	Upgrade	Piper Sandler	Neutral → Overweight	$90 → $110
Aug-24-26	Reiterated	Morgan Stanley	Overweight	$103 → $111
Aug-19-26	Reiterated	Wells Fargo	Overweight	$95 → $109
Aug-06-26	Reiterated	Barclays	Overweight	$94 → $97
Jul-15-26	Reiterated	Atlantic Equities	Overweight	$106 → $103
Jul-10-26	Reiterated	Jefferies	Buy	$82 → $103
Jul-08-26	Reiterated	UBS	Buy	$102 → $105

Latest News· Times ET

Oct-21-26

Oct-21-2611:59PM

MetLife: Momentum Into Q3 Earnings, Big Technical Breakout Tooseekingalpha.com

09:56AM

Why Investors Need to Take Advantage of These 2 Finance Stocks Nowzacks.com

05:43AM

TD Cowen Maintains Buy on MetLife, Raises Price Target to $114Benzinga

Oct-19-26

Oct-19-2610:36AM

MetLife's ChatGPT Integration Opens a New Pet Insurance Growth Avenuezacks.com

09:20AM

Buy 5 Stocks to Stay Safe as Volatility Reappears on Wall Streetzacks.com

Oct-16-26

Oct-16-2601:53PM

Coca-Cola, Visa and Mastercard Hit Records as Investors Rotate Out of Chip StocksYahoo

Oct-12-26

Oct-12-2606:48AM

Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $110Benzinga

Oct-07-26

Oct-07-2604:15PM

MetLife to Announce Third Quarter 2026 Resultsbusinesswire.com

02:00PM

5 Insurance Stocks Built to Keep Paying Dividends Through Hurricanes and Market Crashes247wallst.com

07:31AM

MetLife, Inc. (NYSE:MET) Plans Quarterly Dividend of $0.59defenseworld.net

Oct-06-26

Oct-06-2604:15PM

MetLife Declares Fourth Quarter 2026 Common Stock DividendYahoo

09:20AM

Michael Burry Warns of Risks for These Stocksgurufocus.com

Oct-05-26

Oct-05-2601:07PM

Argent Capital Management LLC Buys 121,303 Shares of MetLife, Inc. $METdefenseworld.net

Sep-29-26

Sep-29-2608:12AM

Michael Burry Turns More Bearish on AI With New 2027 Put BetsYahoo

Sep-22-26

Sep-22-2612:21PM

Can MetLife's Group Benefits Segment Maintain Its Momentum?zacks.com

Company

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

Ownership

Total institutional ownership70.02%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	78,646	77,084	69,939	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	58,550	49,060	50,940	—	—	—	—	—	—
Gross Profit	20,096	28,024	18,999	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	3,216	0	5,991	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	12,012	23,363	7,386	—	—	—	—	—	—
Operating Income	4,868	4,661	5,622	—	—	—	—	—	—
Interest Expense	1,091	1,061	1,037	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	1,092	1,061	1,037	—	—	—	—	—	—
Net Income Before Taxes	4,869	4,661	5,622	—	—	—	—	—	—
Income Taxes	1,210	1,258	1,178	—	—	—	—	—	—
Consolidated Net Income	3,626	3,379	4,426	—	—	—	—	—	—
Net Income From Continuing Operations	3,659	3,403	4,444	—	—	—	—	—	—
Net Income	3,626	3,379	4,426	—	—	—	—	—	—
EPS (Recurring)	5.25	4.80	5.98	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	5.25	4.80	5.98	—	—	—	—	—	—
EPS (Diluted)	5.21	4.80	5.94	—	—	—	—	—	—
EBITDA	5,960	6,475	7,373	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	18.97	16.45	13.78	—	—	—	—	—	—
Price To Sales Ratio	0.82	0.68	0.81	—	—	—	—	—	—
Gross Margin	25.55	36.36	27.17	—	—	—	—	—	—
Operating Margin	6.19	6.05	8.04	—	—	—	—	—	—
Net Margin	4.61	4.38	6.33	—	—	—	—	—	—
Shares Outstanding	652	665	689	—	—	—	—	—	—
Market Capitalization	64,431	52,495	56,415	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PAPPAS BILL	EVP, Global Tech. & Ops.	May 12 '25	Sale	80.49	26,000	2,092,683	66,744	May 13
DEBEL MARLENE	EVP & Chief Risk Officer	Dec 13 '24	Option Exercise	39.26	22,810	895,428	131,317	Dec 17
DEBEL MARLENE	EVP & Chief Risk Officer	Dec 13 '24	Sale	82.88	22,810	1,890,577	108,507	Dec 17
Khalaf Michel	President & CEO	Dec 13 '24	Option Exercise	45.91	26,138	1,199,996	521,725	Dec 17
Khalaf Michel	President & CEO	Dec 13 '24	Sale	82.84	20,926	1,733,604	500,799	Dec 17
PAPPAS BILL	EVP, Global Tech. & Ops.	Mar 18 '24	Sale	72.27	27,000	1,951,325	57,768	Mar 20
TADROS RAMY	President, U.S. Business	Mar 13 '24	Sale	71.90	4,026	289,479	146,981	Mar 14

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.